FDA review backs anti-clot drug from biotech goat's milk

01/7/2009 | USA Today

The FDA released a review of GTC Biotherapeutics' Atryn stating that the treatment proved safe and effective in preventing blood clots. The agency's Blood Products Advisory Board is scheduled Friday to discuss the report on the drug, which is derived from milk of biotech goats.

View Full Article in:

USA Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ